{"result": "(\"entity\"<|>PRACTICAL GASTROENTEROLOGY<|>ORGANIZATION<|>Practical Gastroenterology is a publication that discusses various topics related to gastrointestinal health and nutrition.)\n##\n(\"entity\"<|>BIBBY AC<|>PERSON<|>Bibby AC is an author who contributed to the research on nutritional management in chyle leaks and chylous effusions.)\n##\n(\"entity\"<|>MASKELL NA<|>PERSON<|>Maskell NA is an author who collaborated on the study of nutritional management in chyle leaks and chylous effusions.)\n##\n(\"entity\"<|>ALFANO V<|>PERSON<|>Alfano V is an author who researched the effects of a hypolipidic, MCT-enriched diet on primitive intestinal lymphangiectasia.)\n##\n(\"entity\"<|>TRITTO G<|>PERSON<|>Tritto G is an author involved in the study of dietary modifications for intestinal lymphangiectasia.)\n##\n(\"entity\"<|>ALFONSI L<|>PERSON<|>Alfonsi L is an author who contributed to the research on dietary management in gastrointestinal conditions.)\n##\n(\"entity\"<|>CELLA A<|>PERSON<|>Cella A is an author who worked on the study of dietary interventions for chyle leaks.)\n##\n(\"entity\"<|>PASANINI F<|>PERSON<|>Pasanini F is an author who contributed to the research on nutritional management in gastrointestinal conditions.)\n##\n(\"entity\"<|>CONTALDO F<|>PERSON<|>Contaldo F is an author who researched dietary modifications for chyle leaks and chylous effusions.)\n##\n(\"entity\"<|>JENSEN GL<|>PERSON<|>Jensen GL is an author who studied dietary modification of chyle composition in chylothorax.)\n##\n(\"entity\"<|>MASCIOLI EA<|>PERSON<|>Mascioli EA is an author who contributed to the research on dietary management in chylothorax.)\n##\n(\"entity\"<|>MEYER LP<|>PERSON<|>Meyer LP is an author involved in the study of dietary modifications for chylothorax.)\n##\n(\"entity\"<|>LOPES SM<|>PERSON<|>Lopes SM is an author who contributed to the research on dietary management in chylothorax.)\n##\n(\"entity\"<|>BELL SJ<|>PERSON<|>Bell SJ is an author who studied dietary modifications for chylothorax.)\n##\n(\"entity\"<|>BABAYAN VK<|>PERSON<|>Babayan VK is an author who researched medium-chain triglycerides and their effects on nutrition.)\n##\n(\"entity\"<|>BLACKBURN GL<|>PERSON<|>Blackburn GL is an author who contributed to the study of dietary management in gastrointestinal conditions.)\n##\n(\"entity\"<|>BISTRIAN BR<|>PERSON<|>Bistrian BR is an author involved in the research on dietary modifications for chylothorax.)\n##\n(\"entity\"<|>N. VIRGILI CASAS<|>PERSON<|>N. Virgili Casas is an author who worked on controlled diets in triglycerides.)\n##\n(\"entity\"<|>M.FORGA VISA<|>PERSON<|>M.Forga Visa is an author who contributed to the research on dietary management in triglycerides.)\n##\n(\"entity\"<|>E. GARCÍA RAIMUNDO<|>PERSON<|>E. García Raimundo is an author involved in the study of controlled diets in triglycerides.)\n##\n(\"entity\"<|>RAMOS W<|>PERSON<|>Ramos W is an author who studied nutritional management of thoracic duct fistulas.)\n##\n(\"entity\"<|>FAINTUCH J<|>PERSON<|>Faintuch J is an author who collaborated on the comparative study of nutritional management.)\n##\n(\"entity\"<|>MARTÍNEZ BROCCA MA<|>PERSON<|>Martínez Brocca MA is an author who researched nutritional support in chylothorax secondary to lymphoma.)\n##\n(\"entity\"<|>GARCÍA GARCÍA-DONCEL L<|>PERSON<|>García García-Doncel L is an author involved in the study of nutritional support in chylothorax.)\n##\n(\"entity\"<|>PERERA CUNILL JL<|>PERSON<|>Perera Cunill JL is an author who contributed to the research on nutritional support in chylothorax.)\n##\n(\"entity\"<|>ORTEGÓN ALCALDE S<|>PERSON<|>Ortegón Alcalde S is an author who studied nutritional support in chylothorax.)\n##\n(\"entity\"<|>MARTINO GALIANO ML<|>PERSON<|>Martino Galiano ML is an author involved in the research on nutritional support in chylothorax.)\n##\n(\"entity\"<|>GARCÍA LUNA PP<|>PERSON<|>García Luna PP is an author who contributed to the study of nutritional support in chylothorax.)\n##\n(\"entity\"<|>KELLY RF<|>PERSON<|>Kelly RF is an author who studied conservative management of postoperative chylothorax.)\n##\n(\"entity\"<|>SHUMWAY SJ<|>PERSON<|>Shumway SJ is an author who collaborated on the study of postoperative chylothorax management.)\n##\n(\"entity\"<|>HUANG Q<|>PERSON<|>Huang Q is an author who researched chylous ascites treated with total parenteral nutrition.)\n##\n(\"entity\"<|>JIANG ZW<|>PERSON<|>Jiang ZW is an author involved in the study of chylous ascites treatment.)\n##\n(\"entity\"<|>JIANG J<|>PERSON<|>Jiang J is an author who contributed to the research on chylous ascites treatment.)\n##\n(\"entity\"<|>LI N<|>PERSON<|>Li N is an author who studied chylous ascites treatment with total parenteral nutrition.)\n##\n(\"entity\"<|>LI JS<|>PERSON<|>Li JS is an author involved in the research on chylous ascites treatment.)\n##\n(\"entity\"<|>FERRANDIÉRE M<|>PERSON<|>Ferrandiére M is an author who studied chylous ascites following radical nephrectomy.)\n##\n(\"entity\"<|>HAZOUARD E<|>PERSON<|>Hazouard E is an author who contributed to the research on chylous ascites treatment.)\n##\n(\"entity\"<|>GUICHETEAU V<|>PERSON<|>Guicheteau V is an author involved in the study of chylous ascites treatment.)\n##\n(\"entity\"<|>GOUCHET A<|>PERSON<|>Gouchet A is an author who studied chylous ascites treatment following nephrectomy.)\n##\n(\"entity\"<|>BENSENOUCI M<|>PERSON<|>Bensenouci M is an author who contributed to the research on chylous ascites treatment.)\n##\n(\"entity\"<|>LAMOTTE C<|>PERSON<|>Lamotte C is an author involved in the study of chylous ascites treatment.)\n##\n(\"entity\"<|>MERCIER C<|>PERSON<|>Mercier C is an author who studied chylous ascites treatment following nephrectomy.)\n##\n(\"entity\"<|>SHAPIRO AM<|>PERSON<|>Shapiro AM is an author who researched rapid resolution of chylous ascites after transplantation.)\n##\n(\"entity\"<|>BAIN VG<|>PERSON<|>Bain VG is an author who contributed to the study of chylous ascites treatment post-transplantation.)\n##\n(\"entity\"<|>SIGALET DL<|>PERSON<|>Sigalet DL is an author involved in the research on chylous ascites treatment post-transplantation.)\n##\n(\"entity\"<|>KNETEMAN NM<|>PERSON<|>Kneteman NM is an author who studied chylous ascites treatment after transplantation.)\n##\n(\"entity\"<|>AL-ZUBAIRY S<|>PERSON<|>Al-Zubairy S is an author who researched octreotide as a therapeutic option for chylothorax management.)\n##\n(\"entity\"<|>AL-JAZAIRY A<|>PERSON<|>Al-Jazairi A is an author who contributed to the study of octreotide for chylothorax management.)\n##\n(\"entity\"<|>GUILLEM P<|>PERSON<|>Guillem P is an author who studied chylothorax and chyloperitoneum post-operative management.)\n##\n(\"entity\"<|>PORTE H<|>PERSON<|>Porte H is an author involved in the research on chylothorax management.)\n##\n(\"entity\"<|>TRIBOULET JP<|>PERSON<|>Triboulet JP is an author who studied the efficacy of etilefrine in chylothorax management.)\n##\n(\"entity\"<|>LUTZ P<|>PERSON<|>Lutz P is an author who researched transjugular intrahepatic portosystemic shunt in chylothorax treatment.)\n##\n(\"entity\"<|>STRUNK H<|>PERSON<|>Strunk H is an author involved in the study of chylothorax treatment.)\n##\n(\"entity\"<|>SCHILD HH<|>PERSON<|>Schild HH is an author who studied the management of chylothorax due to liver cirrhosis.)\n##\n(\"entity\"<|>SAUERBRUCH T<|>PERSON<|>Sauerbruch T is an author who contributed to the research on chylothorax treatment.)\n##\n(\"entity\"<|>NADOLSKI GJ<|>PERSON<|>Nadolski GJ is an author who studied thoracic duct embolization for chylous effusion.)\n##\n(\"entity\"<|>ITKIN M<|>PERSON<|>Itkin M is an author involved in the research on thoracic duct embolization for chylous effusion.)\n##\n(\"entity\"<|>KUCHARRCZUK JC<|>PERSON<|>Kucharrczuk JC is an author who studied non-operative thoracic duct embolization.)\n##\n(\"entity\"<|>KWAK A<|>PERSON<|>Kwak A is an author who contributed to the research on thoracic duct embolization.)\n##\n(\"entity\"<|>TREROTOLA SO<|>PERSON<|>Trerotola SO is an author involved in the study of thoracic duct embolization.)\n##\n(\"entity\"<|>KAISER LR<|>PERSON<|>Kaiser LR is an author who studied non-operative thoracic duct embolization.)\n##\n(\"entity\"<|>SCHILD H<|>PERSON<|>Schild H is an author who researched percutaneous translymphatic thoracic duct embolization.)\n##\n(\"entity\"<|>HIRNER A<|>PERSON<|>Hirner A is an author involved in the study of thoracic duct embolization.)\n##\n(\"entity\"<|>LITHERLAND B<|>PERSON<|>Litherland B is an author who studied radiological management of chylothorax.)\n##\n(\"entity\"<|>GIVEN M<|>PERSON<|>Given M is an author who contributed to the research on chylothorax management.)\n##\n(\"entity\"<|>LYON S<|>PERSON<|>Lyon S is an author involved in the study of chylothorax management.)\n##\n(\"relationship\"<|>BIBBY AC<|>PRACTICAL GASTROENTEROLOGY<|>Bibby AC authored a study on nutritional management in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>MASKELL NA<|>PRACTICAL GASTROENTEROLOGY<|>Maskell NA collaborated on a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>ALFANO V<|>PRACTICAL GASTROENTEROLOGY<|>Alfano V contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>TRITTO G<|>PRACTICAL GASTROENTEROLOGY<|>Tritto G is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>ALFONSI L<|>PRACTICAL GASTROENTEROLOGY<|>Alfonsi L contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>CELLA A<|>PRACTICAL GASTROENTEROLOGY<|>Cella A is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>PASANINI F<|>PRACTICAL GASTROENTEROLOGY<|>Pasanini F contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>CONTALDO F<|>PRACTICAL GASTROENTEROLOGY<|>Contaldo F is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>JENSEN GL<|>PRACTICAL GASTROENTEROLOGY<|>Jensen GL authored a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>MASCIOLI EA<|>PRACTICAL GASTROENTEROLOGY<|>Mascioli EA contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>MEYER LP<|>PRACTICAL GASTROENTEROLOGY<|>Meyer LP is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>LOPES SM<|>PRACTICAL GASTROENTEROLOGY<|>Lopes SM contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>BELL SJ<|>PRACTICAL GASTROENTEROLOGY<|>Bell SJ is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>BABAYAN VK<|>PRACTICAL GASTROENTEROLOGY<|>Babayan VK contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>BLACKBURN GL<|>PRACTICAL GASTROENTEROLOGY<|>Blackburn GL is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>BISTRIAN BR<|>PRACTICAL GASTROENTEROLOGY<|>Bistrian BR contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>N. VIRGILI CASAS<|>PRACTICAL GASTROENTEROLOGY<|>N. Virgili Casas authored a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>M.FORGA VISA<|>PRACTICAL GASTROENTEROLOGY<|>M.Forga Visa contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>E. GARCÍA RAIMUNDO<|>PRACTICAL GASTROENTEROLOGY<|>E. García Raimundo is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>RAMOS W<|>PRACTICAL GASTROENTEROLOGY<|>Ramos W authored a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>FAINTUCH J<|>PRACTICAL GASTROENTEROLOGY<|>Faintuch J contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>MARTÍNEZ BROCCA MA<|>PRACTICAL GASTROENTEROLOGY<|>Martínez Brocca MA is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>GARCÍA GARCÍA-DONCEL L<|>PRACTICAL GASTROENTEROLOGY<|>García García-Doncel L contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>PERERA CUNILL JL<|>PRACTICAL GASTROENTEROLOGY<|>Perera Cunill JL is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>ORTEGÓN ALCALDE S<|>PRACTICAL GASTROENTEROLOGY<|>Ortegón Alcalde S contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>MARTINO GALIANO ML<|>PRACTICAL GASTROENTEROLOGY<|>Martino Galiano ML is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>GARCÍA LUNA PP<|>PRACTICAL GASTROENTEROLOGY<|>García Luna PP contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>KELLY RF<|>PRACTICAL GASTROENTEROLOGY<|>Kelly RF authored a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>SHUMWAY SJ<|>PRACTICAL GASTROENTEROLOGY<|>Shumway SJ contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>HUANG Q<|>PRACTICAL GASTROENTEROLOGY<|>Huang Q authored a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>JIANG ZW<|>PRACTICAL GASTROENTEROLOGY<|>Jiang ZW contributed to research published in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>JIANG J<|>PRACTICAL GASTROENTEROLOGY<|>Jiang J is an author of a study in Practical Gastroenterology<|>7)\n##\n(\"relationship\"<|>LI N<|>PRACTICAL GASTROENTEROLOGY<|>Li N contributed to research published in Practical Gastro", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Practical Gastroenterology 2011; 12-30\n26. Bibby AC, Maskell NA. Nutritional management in chyle leaks and chylous effusions. Br J Comun Nurs 2014; S6-S9.\n27. Alfano V, Tritto G, Alfonsi L, Cella A, Pasanini F, Contaldo F. Stable reversal of pathologic signs of primitive intestinal lymphangiectasia with hypolipidic, MCT-enriched diet. Nutrition 2000; 16:303-304.\n28. Bach A.C, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982; 36:950-962.\n29. Jensen Gl, Mascioli EA, Meyer LP, Lopes SM, Bell SJ, Babayan VK, Blackburn Gl, Bistrian BR. Dietary modification of chyle composition in chylothorax. Gastroenterology 1989; 97; 761-5.\n30. N. Virgili Casas, M.Forga Visa, E. García Raimundo. Dieta controlada en triglicéridos de cadena larga y en triglicéridos de cadena media. En: Nutrición y dietética clínica. 2ª edición. Salas Salvadó J, Bonada Sanjaume A, Trallero Casañas R, Saló i Solà ME, Burgos Pelaez R. Barcelona 2014, pag:361-368.\n---\nTema 21. Quilotórax y ascitis quilosa. Dietas modificadas en triglicéridos...    363\n\n31. Ramos W, Faintuch J. Nutritional management of thoracic duct fistulas. A comparative study of parenteral versus enteral nutrition. JPEN 1986; 10:519-521.\n\n32. Martínez Brocca MA, García García-Doncel L, Perera Cunill JL, Ortegón Alcalde S, Martino Galiano ML, García Luna PP. Soporte nutricional en el quilotórax secundario a linfoma. Nutr Hosp. 2002; 17:43-45.\n\n33. Sirvent Ochando M, Lopez Villodre P, Martínez Seguí MJ. Soporte nutricional y tratamiento con octreotida del quilotórax. Nutr Hosp 2010; 25:113-119.\n\n34. Kelly RF, Shumway SJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg 2000; 69:1944-1945.\n\n35. Huang Q, Jiang ZW, Jiang J, Li N, Li JS. Chylous ascites: treated with total parenteral nutrition and somatostatin. World J Gastroenterol 2004; 10: 2588-2591.\n\n36. Ferrandiére M, Hazouard E, Guicheteau V, Gouchet A, Bensenouci M, Lamotte C, Mercier C. Chylous ascites following radical nephrectomy: efficiency of octreotide as treatment of a ruptured thoracic duct. Intensive Care 2000; 26: 484-485.\n\n37. Shapiro AM, Bain VG, Sigalet DL, Kneteman NM. Rapid resolution of chylous ascites after transplantation using somatostatin analog and total parenteral nutrition. Transplantation 1996; 61:1410-1411.\n\n38. Al-Zubairy S., Al-Jazairi A. Octreotide as a therapeutic option for management of chylothorax. Ann Pharmacother 2003; 37:679-82.\n\n39. Guillem P, Porte H, Triboulet JP. Chylothorax et chyloperitoneum post-operatoires. Efficacité de l'etilefrine. J Chir Thor Cardiovasc 1999; 3:70.\n\n40. Lutz P, Strunk H, Schild HH, Sauerbruch T. Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis. World J Gastroenterol 2013; 19:1140-2\n\n41. Alejandre-Lafont E, Krompiec C, Rau WS, Krombach GA. Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiol 2011; 52:305-11\n\n42. Nadolski GJ, Itkin M. Thoracic duct embolization for nontraumatic chylous effusion: Experience in 34 patients. Chest 2013; 143:158-63.\n\n43. Itkin M, Kucharrczuk JC, Kwak A, Trerotola SO, Kaiser LR. Non-operative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg 2010; 139:584-9\n\n44. Schild H, Hirner A. Percutaneous translymphatic thoracic duct embolization for treatment of chylothorax. RöFo 2001; 173:580-2\n\n45. Litherland B, Given M, Lyon S. Percutaneous radiological management of high output chylothorax with CT-guided needle disruption. J Med Imaging Radiat Oncol 2008; 52:164-7.\n---\nThe\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}